Santen Pharmaceutical Co., Ltd. (SNPHY)
OTCMKTS · Delayed Price · Currency is USD
10.71
+0.76 (7.58%)
May 15, 2025, 2:36 PM EDT

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2016 - 2018
Prescription Drugs
281.03B
Log In
Log In
Log In
Log In
Upgrade
Prescription Drugs Growth
7.99%
Log In
Log In
Log In
Log In
Upgrade
Over-the-counter Drugs
11.24B
Log In
Log In
Log In
Log In
Upgrade
Over-the-counter Drugs Growth
5.78%
Log In
Log In
Log In
Log In
Upgrade
Medical Equipment
7.77B
Log In
Log In
Log In
Log In
Upgrade
Medical Equipment Growth
24.13%
Log In
Log In
Log In
Log In
Upgrade
Other
1.93B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
0.63%
Log In
Log In
Log In
Log In
Upgrade
Other
1.93B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
0.63%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2016 - 2018
Japan
175.61B
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
-1.00%
Log In
Log In
Log In
Log In
Upgrade
EMEA
64.76B
Log In
Log In
Log In
Log In
Upgrade
EMEA Growth
23.31%
Log In
Log In
Log In
Log In
Upgrade
China
29.86B
Log In
Log In
Log In
Log In
Upgrade
China Growth
38.58%
Log In
Log In
Log In
Log In
Upgrade
Asia
28.67B
Log In
Log In
Log In
Log In
Upgrade
Asia Growth
18.86%
Log In
Log In
Log In
Log In
Upgrade
Americas
3.08B
Log In
Log In
Log In
Log In
Upgrade
Americas Growth
-11.75%
Log In
Log In
Log In
Log In
Upgrade